Biomea Fusion Stock Performance
| BMEA Stock | USD 1.85 0.03 1.60% |
On a scale of 0 to 100, Biomea Fusion holds a performance score of 3. The firm shows a Beta (market volatility) of 3.12, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biomea Fusion will likely underperform. Please check Biomea Fusion's jensen alpha, maximum drawdown, semi variance, as well as the relationship between the sortino ratio and potential upside , to make a quick decision on whether Biomea Fusion's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Biomea Fusion are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Biomea Fusion sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Acquisition by Michael Hitchcock of 350000 shares of Biomea Fusion at 2.52 subject to Rule 16b-3 | 05/01/2025 |
2 | Biomea Fusion Receives Overweight Rating from Piper Sandler BMEA Stock News | 06/02/2025 |
3 | Acquisition by Chen Bihua of 91970 shares of Biomea Fusion at 2.5 subject to Rule 16b-3 | 06/11/2025 |
4 | Biomea Fusion Launches Public Offering with Warrants BMEA Stock News | 06/17/2025 |
5 | Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppr... | 06/18/2025 |
6 | Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association | 06/23/2025 |
7 | Biomea Fusion Sees Significant Borrow Rate Increase BMEA Stock News | 06/25/2025 |
8 | Biomea Fusions Phase 2 Trial A New Hope for Type 1 Diabetes Treatment - TipRanks | 07/03/2025 |
9 | Biomea Fusion Stock Update Citigroup Lowers Price Target BMEA Stock News | 07/16/2025 |
| Begin Period Cash Flow | 177.2 M | |
| Total Cashflows From Investing Activities | -362 K |
Biomea Fusion Relative Risk vs. Return Landscape
If you would invest 195.00 in Biomea Fusion on April 22, 2025 and sell it today you would lose (10.00) from holding Biomea Fusion or give up 5.13% of portfolio value over 90 days. Biomea Fusion is currently generating 0.4652% in daily expected returns and assumes 11.0581% risk (volatility on return distribution) over the 90 days horizon. In different words, 99% of stocks are less volatile than Biomea, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biomea Fusion Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomea Fusion's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biomea Fusion, and traders can use it to determine the average amount a Biomea Fusion's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0421
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BMEA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.06 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.47 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Biomea Fusion is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biomea Fusion by adding it to a well-diversified portfolio.
Biomea Fusion Fundamentals Growth
Biomea Stock prices reflect investors' perceptions of the future prospects and financial health of Biomea Fusion, and Biomea Fusion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biomea Stock performance.
| Return On Equity | -1.57 | ||||
| Return On Asset | -0.74 | ||||
| Current Valuation | 77.55 M | ||||
| Shares Outstanding | 57.02 M | ||||
| Price To Book | 3.67 X | ||||
| EBITDA | (136.68 M) | ||||
| Net Income | (138.43 M) | ||||
| Cash And Equivalents | 149.63 M | ||||
| Cash Per Share | 5.11 X | ||||
| Total Debt | 8.77 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 16.46 X | ||||
| Book Value Per Share | 0.77 X | ||||
| Cash Flow From Operations | (119.89 M) | ||||
| Earnings Per Share | (3.54) X | ||||
| Market Capitalization | 105.49 M | ||||
| Total Asset | 79.94 M | ||||
| Retained Earnings | (387.25 M) | ||||
| Working Capital | 46.66 M | ||||
About Biomea Fusion Performance
By analyzing Biomea Fusion's fundamental ratios, stakeholders can gain valuable insights into Biomea Fusion's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biomea Fusion has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biomea Fusion has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.73) | (1.82) | |
| Return On Capital Employed | (2.47) | (2.35) | |
| Return On Assets | (1.73) | (1.82) | |
| Return On Equity | (2.68) | (2.55) |
Things to note about Biomea Fusion performance evaluation
Checking the ongoing alerts about Biomea Fusion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biomea Fusion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biomea Fusion had very high historical volatility over the last 90 days | |
| Biomea Fusion may become a speculative penny stock | |
| Biomea Fusion has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (138.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biomea Fusion currently holds about 149.63 M in cash with (119.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Biomea Fusion has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Biomea Fusion Stock Update Citigroup Lowers Price Target BMEA Stock News |
- Analyzing Biomea Fusion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biomea Fusion's stock is overvalued or undervalued compared to its peers.
- Examining Biomea Fusion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biomea Fusion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biomea Fusion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biomea Fusion's stock. These opinions can provide insight into Biomea Fusion's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biomea Stock analysis
When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |